Strategy "treat to target" for patients with psoriasis. Relevant issues to biological therapy persistence
The review discusses the possibility of result-oriented treatment therapeutic strategy (Т2Т) for patients with psoriasis implementation, as well as analysis of the key factors to ensure stability of long-term therapy with the use of genetically engineered biological drugs. It contains data on target...
Saved in:
Main Author: | A. L. Bakulev (Author) |
---|---|
Format: | Book |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Actual Challenges of Biologics Treatment in Patients with Psoriasis
by: Andrey L. Bakulev
Published: (2020) -
Psoriasis: clinical and epidemiological features and therapy issues
by: A. L. Bakulev, et al.
Published: (2018) -
Evolution of the understanding of psoriasis and therapeutic approaches used to manage such patients. BCD-085 is the first Russian genetically-engineered biological preparation for the treatment of patients suffering from psoriasis
by: A. L. Bakulev
Published: (2019) -
Psoriasis in areas difficult to treat and biological therapy
by: Anna Lis-Święty, et al.
Published: (2021) -
Systemic Psoriasis Treatment at an Early Age (Part II): Issues of Biological Therapy
by: L. S. Namazova-Baranova, et al.
Published: (2018)